Transenterix Inc (NASDAQ:TRXC)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $1.10, but opened at $1.15. Transenterix shares last traded at $1.22, with a volume of 587,912 shares.

Separately, Zacks Investment Research raised Transenterix from a “hold” rating to a “buy” rating and set a $0.75 price target for the company in a research note on Thursday, July 13th.

The stock has a 50 day moving average of $0.80 and a 200 day moving average of $0.83. The stock’s market capitalization is $201.27 million.

A number of hedge funds have recently modified their holdings of the business. Royal Bank of Canada grew its position in shares of Transenterix by 17.1% during the second quarter. Royal Bank of Canada now owns 418,867 shares of the company’s stock valued at $298,000 after purchasing an additional 61,034 shares in the last quarter. Global X Management Co. LLC grew its position in shares of Transenterix by 238.3% during the second quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock valued at $235,000 after purchasing an additional 233,213 shares in the last quarter. LMR Partners LLP purchased a new position in shares of Transenterix during the second quarter valued at about $189,000. UBS Oconnor LLC purchased a new position in shares of Transenterix during the second quarter valued at about $390,000. Finally, Goldman Sachs Group Inc. grew its position in shares of Transenterix by 7,137.7% during the second quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock valued at $854,000 after purchasing an additional 1,186,575 shares in the last quarter.

ILLEGAL ACTIVITY NOTICE: “Transenterix Inc (TRXC) Shares Gap Up to $1.15” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another domain, it was stolen and republished in violation of U.S. and international copyright laws. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/09/14/transenterix-inc-trxc-shares-gap-up-to-1-15.html.

Transenterix Company Profile

TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.

Receive News & Stock Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related stocks with our FREE daily email newsletter.